Mkts

Amphastar Pharmaceuticals, Inc.

NASDAQ: AMPH
$25.14-0.90 (-3.46%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
24.6225.91
52-week range
16.6529.52
Today
Open25.91
Previous close25.14
Volume632.0K
Valuation
Market cap1.11B
P/E ratio14.10×
EPS (TTM)1.71
Income & risk
Dividend / yield—
Beta0.96
Avg volume484.5K
Discussion

AMPH News

Stories mentioning AMPH from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue171,171183,105191,840174,414170,528186,523191,214182,394
Cost of Goods Sold100,84997,43593,19487,92485,27799,87589,27387,228
Gross Profit70,32285,67098,64686,49085,25186,648101,94195,166
Operating Expenses
Research & Development26,73723,31422,35420,08020,09618,14221,07717,652
Sales General & Admin
Total Operating Expenses56,69250,06473,32644,30647,95841,50444,89339,949
Operating Income (Loss)13,63035,60625,32042,18437,29345,14457,04855,217
Interest Income2,4002,4232,2461,9212,0892,2922,4273,337
Interest Expense
Other Expense575.00515.00231.001,511(2,234)2,951(5,094)298.00
Pretax Income10,05231,91421,51339,33530,86243,96247,68350,243
Tax Provision3,6327,4854,1638,3055,5775,9987,25412,294
Net Income (Loss)6,42024,42917,35031,03025,28537,96440,42937,949
Earnings Per Share (Basic)0.140.520.380.660.530.780.830.77
Earnings Per Share (Diluted)0.140.510.370.640.510.730.780.73
Weighted Average Shares Outstanding (Basic)45,32246,74346,47446,94947,64148,42948,62148,907
Weighted Average Shares Outstanding (Diluted)46,45848,21547,67748,12849,89052,05851,86252,046

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AMPH

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMPH. It last traded at $25.14 (Oct 23, 2026, 4:00 PM ET), down 3.5% on the day. That gives Amphastar Pharmaceuticals a market capitalisation of $1.1B and a price-to-earnings ratio of 14.1.

Over the past 52 weeks AMPH has traded between $16.65 and $29.52.

Revenue for the quarter ended Mar 31, 2026 was $171.2M; net income $6.4M. Revenue was up 0.4% from $170.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$171.2M$6.4M3.8%
Dec 31, 2025$183.1M$24.4M13.3%
Sep 30, 2025$191.8M$17.4M9.0%
Jun 30, 2025$174.4M$31.0M17.8%

From Amphastar Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…